Chemical Structure : MK-591
CAS No.: 147030-01-1
Catalog No.: PC-45853Not For Human Use, Lab Use Only.
Quiflapon (MK-591, MK-0591, L-686708) sodium is a potent, orally active leukotriene biosynthesis inhibitor that acts by inhibiting 5-lipoxygenase activating protein (FLAP) with IC50 of 1.6 nM in a FLAP binding assay.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $118 | In stock | |
10 mg | $178 | In stock | |
25 mg | $298 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Quiflapon (MK-591, MK-0591, L-686708) sodium is a potent, orally active leukotriene biosynthesis inhibitor that acts by inhibiting 5-lipoxygenase activating protein (FLAP) with IC50 of 1.6 nM in a FLAP binding assay.
Quiflapon (MK-591) inhibits leukotriene (LT) biosynthesis in intact human and elicited rat PMNLs with IC50 of 3.1 nM and 6.1 nM, respectively.
Quiflapon (MK-591) inhibits the systemic generation of peptidoleukotrienes as measured by urinary LTE4 excretion in dogs (ED50=1 mg/kg).
M.Wt | 609.1531 | |
Formula | C34H34ClN2NaO3S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-α,α-dimethyl-5-(2-quinolinylmethoxy)-, sodium salt (1:1) |
1. Brideau C, et al. Can J Physiol Pharmacol. 1992 Jun;70(6):799-807.
2. Ménard L, et al. Can J Physiol Pharmacol. 1992 Jun;70(6):808-13.
3. Tagari P, et al. J Pharmacol Exp Ther. 1993 Apr;265(1):416-25.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright